Gsk (GSK) Dividends Paid - Common (2009 - 2026)
Gsk (GSK) posted quarterly Dividends Paid - Common of -$866.9 million for Q1 2026, down 12.46% year-over-year from -$990.3 million in Q1 2025, and up 48.6% quarter-over-quarter from -$1.7 billion in Q4 2025.
Gsk (GSK) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Gsk's Dividends Paid - Common history runs 18 years deep, the most recent figure standing at -$866.9 million for Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 12.46% year-over-year to -$866.9 million; the TTM figure through Mar 2026 stood at -$2.8 billion (down 10.43% YoY), while the FY2025 annual figure was $3.4 billion, up 8.21% from the prior year.
- Dividends Paid - Common for Q1 2026 stood at -$866.9 million, up from -$1.7 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was -$72.2 million in Q3 2023, with the low at -$2.5 billion in Q4 2022.
- The 5-year median for Dividends Paid - Common is -$674.6 million (2023), against an average of -$739.7 million.
- The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common sank 58.34% in 2022, then jumped 71.24% in 2023.
- Gsk's Dividends Paid - Common stood at -$2.5 billion in 2022, then jumped by 44.18% to -$1.4 billion in 2023, then retreated by 13.46% to -$1.6 billion in 2024, then slipped by 7.71% to -$1.7 billion in 2025, then soared by 48.6% to -$866.9 million in 2026.
- Business Quant data shows GSK's Dividends Paid - Common at -$866.9 million in Q1 2026, -$1.7 billion in Q4 2025, and -$133.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -866.88 Mn |
| Mar 31, 2026 | -866.88 Mn |
| Dec 31, 2025 | -1.69 Bn |
| Dec 31, 2025 | -1.69 Bn |
| Sep 30, 2025 | -133.59 Mn |
| Sep 30, 2025 | -133.59 Mn |
| Jun 30, 2025 | -162.75 Mn |
| Jun 30, 2025 | -162.75 Mn |
| Mar 31, 2025 | -770.81 Mn |
| Mar 31, 2025 | -770.81 Mn |
| Dec 31, 2024 | -1.57 Bn |
| Dec 31, 2024 | -1.57 Bn |
| Sep 30, 2024 | -103.94 Mn |
| Sep 30, 2024 | -103.94 Mn |
| Jun 30, 2024 | -140.11 Mn |
| Jun 30, 2024 | -140.11 Mn |
| Mar 31, 2024 | -720.52 Mn |
| Mar 31, 2024 | -720.52 Mn |
| Dec 31, 2023 | -1.38 Bn |
| Dec 31, 2023 | -1.38 Bn |